Cargando…

Hydroxyurea Treatment in Transfusion-Dependent β-Thalassemia Patients

BACKGROUND: β-Thalassemia is an inherited hemoglobin disorder caused by defective synthesis of ß-globin chains. Hemoglobin (Hb) F induction is a possible therapeutic approach which can partially compensate for α and non-α globin chains imbalance. OBJECTIVES: We aimed to investigate the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bordbar, Mohammad Reza, Silavizadeh, Samir, Haghpanah, Sezaneh, Kamfiroozi, Roza, Bardestani, Marzieh, Karimi, Mehran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102988/ https://www.ncbi.nlm.nih.gov/pubmed/25068055 http://dx.doi.org/10.5812/ircmj.18028

Ejemplares similares

Frequency of Cholelithiasis in Patients With Beta-Thalassemia Intermedia With and Without Hydroxyurea
por: Khavari, Maryam, et al.
Publicado: (2014)

Comparative Study of Radiographic and Laboratory Findings Between Beta Thalassemia Major and Beta Thalassemia Intermedia Patients With and Without Treatment by Hydroxyurea
por: Abolhasani Foroughi, Amin, et al.
Publicado: (2015)

Serum Ferritin Levels Correlation With Heart and Liver MRI and LIC in Patients With Transfusion-Dependent Thalassemia
por: Majd, Zahra, et al.
Publicado: (2015)

Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea
por: Zekavat, Omid Reza, et al.
Publicado: (2014)

Ocular findings in patients with transfusion-dependent β-thalassemia in southern Iran
por: Haghpanah, Sezaneh, et al.
Publicado: (2020)

Complementary and alternative medicine use in thalassemia patients in Shiraz, southern Iran: A cross-sectional study
por: Bordbar, Mohammadreza, et al.
Publicado: (2017)

Optical coherence tomography findings in patients with transfusion-dependent β-thalassemia
por: Haghpanah, Sezaneh, et al.
Publicado: (2022)

Relationship Between Serum Hepcidin and Ferritin Levels in Patients With Thalassemia Major and Intermedia in Southern Iran
por: Haghpanah, Sezaneh, et al.
Publicado: (2015)

Prevalence and Severity of Coronavirus Disease 2019 (COVID-19) in Transfusion Dependent and Non-Transfusion Dependent β -Thalassemia Patients and effects of Associated Comorbidities: An Iranian Nationwide study
por: Karimi, Mehran, et al.
Publicado: (2020)

β-Thalassemia: New Therapeutic Modalities, Genetics, Complications, and Quality of Life
por: Karimi, Mehran, et al.
Publicado: (2012)

Diffuse Hepatic Calcifications in a Transfusion-Dependent Patient with Beta-Thalassemia: A Case Report
por: Saki, Forough, et al.
Publicado: (2013)

Efficacy of Hydroxyurea in Transfusion-Dependent Major β-Thalassemia Patients: A Meta-Analysis
por: Hatamleh, Modather I, et al.
Publicado: (2023)

Serum lipid profiles in patients with beta-thalassemia major and intermedia in southern Iran
por: Haghpanah, Sezaneh, et al.
Publicado: (2010)

Coronavirus Disease 2019 (COVID-19) Severity in Patients with Thalassemias: A Nationwide Iranian Experience
por: Karimi, Mehran, et al.
Publicado: (2021)

The Frequency of Adrenal Insufficiency in Adolescents and Young Adults with Thalassemia Major versus Thalassemia Intermedia in Iran
por: Matin, Sara, et al.
Publicado: (2015)

Epidemiological and Clinical Characteristics of Neuroblastoma in Southern Iran
por: Bordbar, MR, et al.
Publicado: (2014)

The frequency of hypothyroidism and its relationship with HCV positivity in patients with thalassemia major in southern Iran
por: Haghpanah, Sezaneh, et al.
Publicado: (2018)

The survival of childhood leukemia: An 8‐year single‐center experience
por: Bordbar, Mohammadreza, et al.
Publicado: (2023)

Evaluation of Knowledge of Patients with Hemophilia Regarding Their Diseases and Treatment in Iran
por: Karimi, Mehran, et al.
Publicado: (2016)

Evaluation of the combination therapy of hydroxyurea and thalidomide in β-thalassemia
por: Ansari, Saqib H., et al.
Publicado: (2022)

Efficacy and Safety of Hydroxyurea as Adjuvant Therapy in Pediatric Patients of Transfusion-Dependent Beta-Thalassemia Major at Zhob, Balochistan
por: Akram, Sumera, et al.
Publicado: (2022)

A Phase 2 Randomized Controlled Trial of Single-Agent Hydroxyurea Versus Thalidomide Among Adult Transfusion Dependent β Thalassemia Patients
por: Bhattacharjee, Urmimala, et al.
Publicado: (2023)

Phenotype Report on Patients with Congenital Factor V Deficiency in Southern Iran: Recent Ten Years’ Experience
por: Safarpour, Mohammad Mostafa, et al.
Publicado: (2017)

Alloimmunization among transfusion-dependent thalassemia patients
por: Sadeghian, Mohammad Hadi, et al.
Publicado: (2009)

Health state utilities associated with treatment for transfusion-dependent β-thalassemia
por: Matza, Louis S., et al.
Publicado: (2019)

Comparison of the clinical features and outcome of children with hemophagocytic lymphohistiocytosis (HLH) secondary to visceral leishmaniasis and primary HLH: a single-center study
por: Mottaghipisheh, Hadi, et al.
Publicado: (2021)

Skeletal complications in patients with hemophilia: a single-center experience
por: Bordbar, Mohammadreza, et al.
Publicado: (2023)

Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia
por: Musallam, Khaled M., et al.
Publicado: (2021)

Marital status and paternity in patients with Transfusion-Dependent Thalassemia (TDT) and Non Transfusion-Dependent Thalassemia (NTDT): an ICET - A survey in different countries
por: De Sanctis, Vincenzo, et al.
Publicado: (2019)

β-Thalassemia Mutations among Transfusion-Dependent Thalassemia Major Patients in Northern Iraq
por: Al-Allawi, Nasir A. S., et al.
Publicado: (2010)

Luspatercept for transfusion-dependent β-thalassemia: time to get real
por: Musallam, Khaled M., et al.
Publicado: (2023)

How I treat non-transfusion-dependent β-thalassemia
por: Saliba, Antoine N., et al.
Publicado: (2023)

Hemoaction Game: An educational Step to Improve Hemophilia Children and Nurses Self-Efficacy
por: BEHESHTIPOOR, NOOASHIN, et al.
Publicado: (2016)

In Vitro Hb Production in B-thalassemia Patients Is Not a Predictor of Clinical Responsiveness to Hydroxyurea
por: MAHDAVI, Mohammad Reza, et al.
Publicado: (2017)

Renal Hemosiderosis among Iranian Transfusion Dependent β-Thalassemia Major Patients
por: Hashemieh, Mozhgan, et al.
Publicado: (2017)

Molecular Analysis of Non-Transfusion Dependent Thalassemia Associated with Hemoglobin E-β-Thalassemia Disease without α-Thalassemia
por: Phanrahan, Paramee, et al.
Publicado: (2019)

Pulmonary Functions in Transfusion-Dependent Thalassemia
por: Chandra, Jagdish, et al.
Publicado: (2022)

S270: TRANSFUSION INDEPENDENCE AFTER EXAGAMGLOGENE AUTOTEMCEL IN PATIENTS WITH TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA
por: Locatelli, Franco, et al.
Publicado: (2023)

Side effects of hydroxyurea in patients with Thalassemia major and thalassemia intermedia and sickle cell anemia
por: Ghasemi, A, et al.
Publicado: (2014)

Complications in patients with transfusion dependent thalassemia: A descriptive cross‐sectional study
por: Faranoush, Mohammad, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ptrpbhu678aod9k5idfkoijluj